A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma
Phase of Trial: Phase I/II
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms PACT-19
- 12 Sep 2017 Final results from the phase II part, presented at the 42nd European Society for Medical Oncology Congress.
- 31 Aug 2017 Status changed from active, no longer recruiting to completed.
- 18 Apr 2017 Planned End Date changed from 1 Jan 2017 to 1 Jun 2017.